Immunobiologic correlates of prognosis in lymphoma

Seminars in Oncology

Volumn 20, Issue SUPPL. 5, 1993, Pages 58-74

  Grogan, T M ^a   Miller, T P ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; COLLAGENASE; GLYCOPROTEIN P; HERMES ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DR ANTIGEN; HOMING RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LACTATE DEHYDROGENASE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NERVE CELL ADHESION MOLECULE; TISSUE INHIBITOR OF METALLOPROTEINASE;

B CELL LYMPHOMA; CANCER SURVIVAL; CELL INTERACTION; DRUG RESISTANCE; HUMAN; IMMUNOBIOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALIGNANT TRANSFORMATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; T LYMPHOCYTE SUBPOPULATION;

BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CELL TRANSFORMATION, NEOPLASTIC; DNA, NEOPLASM; DRUG RESISTANCE; GENETIC MARKERS; HLA ANTIGENS; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, NON-HODGKIN; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027377241     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)